Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (51-60 of 175) with videos related to

Pageof 18
Sort By:
Gynecologic Oncology|May 23, 2008
In vitro metformin anti-neoplastic activity in epithelial ovarian cancerWalter H Gotlieb, Julio Saumet, Marie-Claude Beauchamp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Dinucleotide repeat in the insulin-like growth factor-I gene is not related to risk of colorectal adenomaEdward Giovannucci, Christopher A Haiman, Elizabeth A Platz, et al.
Cancer Causes & Control : CCC|June 11, 2005
Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA eraElizabeth A Platz, Michael N Pollak, Michael F Leitzmann, et al.
Psychoneuroendocrinology|February 12, 2008
Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetesOlivia I Okereke, Michael N Pollak, Frank B Hu, et al.
American Journal of Epidemiology|August 11, 2011
Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3Elizabeth M Poole, Shelley S Tworoger, Susan E Hankinson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year periodStacey A Missmer, Donna Spiegelman, Elizabeth R Bertone-Johnson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 8, 2013
Plasma C-peptide, mammographic breast density, and risk of invasive breast cancerThomas P Ahern, Susan E Hankinson, Walter C Willett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 12, 2010
Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trialJason B Douglas, Debra T Silverman, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in womenEsther K Wei, Jing Ma, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in womenEsther K Wei, Jing Ma, Michael N Pollak, et al.
Pageof 18

Showing results (51-60 of 175) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|May 23, 2008
In vitro metformin anti-neoplastic activity in epithelial ovarian cancerWalter H Gotlieb, Julio Saumet, Marie-Claude Beauchamp, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Dinucleotide repeat in the insulin-like growth factor-I gene is not related to risk of colorectal adenomaEdward Giovannucci, Christopher A Haiman, Elizabeth A Platz, et al.
Cancer Causes & Control : CCC|June 11, 2005
Plasma insulin-like growth factor-1 and binding protein-3 and subsequent risk of prostate cancer in the PSA eraElizabeth A Platz, Michael N Pollak, Michael F Leitzmann, et al.
Psychoneuroendocrinology|February 12, 2008
Plasma C-peptide levels and rates of cognitive decline in older, community-dwelling women without diabetesOlivia I Okereke, Michael N Pollak, Frank B Hu, et al.
American Journal of Epidemiology|August 11, 2011
Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3Elizabeth M Poole, Shelley S Tworoger, Susan E Hankinson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2006
Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year periodStacey A Missmer, Donna Spiegelman, Elizabeth R Bertone-Johnson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 8, 2013
Plasma C-peptide, mammographic breast density, and risk of invasive breast cancerThomas P Ahern, Susan E Hankinson, Walter C Willett, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 12, 2010
Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trialJason B Douglas, Debra T Silverman, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in womenEsther K Wei, Jing Ma, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 15, 2006
C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in womenEsther K Wei, Jing Ma, Michael N Pollak, et al.
Pageof 18